Skip to main content

Table 1 Baseline characteristics of study participants and medications

From: Low-volume high-intensity interval training improves cardiometabolic health, work ability and well-being in severely obese individuals: a randomized-controlled trial sub-study

 

HIIT (n = 36)

CON (n = 29)

Variable

 Men/women (n)

19/17

10/19

 Age (years)

48.5 ± 10.0

49.0 ± 9.9

 Body mass index (kg/m2)

40.4 ± 7.2

38.5 ± 6.9

 VO2max (mL/kg/min)

21.9 ± 6.2

21.7 ± 7.1

Medications, n (%)

 Beta blockers

2 (5.6%)

3 (10.3%)

 ACE inhibitors

10 (27.8%)

8 (27.6%)

 Non ACE inhibitors

7 (19.4%)

4 (13.8%)

 Metformin

5 (13.9%)

3 (10.3%)

 Exogenous insulin

1 (2.8%)

0

 Anticoagulants

1 (2.8%)

0

 Bronchodilators

1 (2.8%)

1 (3.4%)

 Antihistamines

0

3 (10.3%)

 l-thyroxine

4 (11.1%)

8 (27.6%)

 Analgesics

8 (22.2%)

9 (31.0%)

 Anti-depressants

5 (13.9%)

4 (13.8%)

  1. HIIT High-intensity interval training group, CON control group